Patents by Inventor Aaron Tucker
Aaron Tucker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12293338Abstract: Described herein are methods and systems for generating and applying vehicle maintenance models to vehicle telematics data. A vehicle telematics analytics (VTA) computing device is configured to receive vehicle telematics data associated with operation of a subject vehicle, and apply the received vehicle telematics data to a vehicle maintenance model to determine whether the operation of the subject vehicle is better or worse than standard operation of like vehicles. The VTA computing device may adjust a maintenance cost and/or determine if a user of the vehicle is eligible for a reward based upon this determination. The VTA computing device is configured to transmit an itemized report to the user including the adjusted maintenance cost and/or the reward as well as one or more other vehicle costs.Type: GrantFiled: February 2, 2024Date of Patent: May 6, 2025Assignee: State Farm Mutual Automobile Insurance CompanyInventors: Joseph Robert Brannan, Ryan Michael Gross, Matthew Eric Riley, Sr., Darwin Gene Beachy, Michael Aaron Myers, Brian N. Harvey, Benjamin Joel Tucker, Scott Thomas Christensen
-
Publication number: 20250115924Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: ApplicationFiled: December 2, 2024Publication date: April 10, 2025Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: TIM FOX, WILLIAM JAMES GORDON-KAMM, RACHEL CAROL HUEGEL, KEITH S. LOWE, JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20250115927Abstract: The methods disclosed herein provide for clonal plant production using a morphogenic gene to produce non-transgenic and transgenic plants wherein the morphogenic gene does not integrate into the genome of the plant.Type: ApplicationFiled: October 8, 2024Publication date: April 10, 2025Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: WILLIAM JAMES GORDON-KAMM, KEITH S. LOWE, JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20250101453Abstract: The present disclosure provides methods of generating doubled haploid plants using a polynucleotide sequence encoding the truncated ZM-ODP2 polypeptide for parthenogenic haploid induction and haploid chromosome doubling.Type: ApplicationFiled: March 24, 2023Publication date: March 27, 2025Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: WILLIAM JAMES GORDON-KAMM, JON AARON TUCKER REINDERS, NAGESH SARDESAI, HUAXUN YE
-
Publication number: 20250047040Abstract: A cable termination that helps prevent unwanted, inadvertent electrical shorting between a signal conductor and a cable ground shield, cable serve shield, or cable reference shield of a cable, such as a coaxial or twin axial cable.Type: ApplicationFiled: January 18, 2023Publication date: February 6, 2025Inventors: Aaron TUCKER, Richard L. JONES, III
-
Patent number: 12146147Abstract: The methods disclosed herein provide for clonal plant production using a morphogenic gene to produce non-transgenic and transgenic plants wherein the morphogenic gene does not integrate into the genome of the plant.Type: GrantFiled: March 10, 2020Date of Patent: November 19, 2024Assignee: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: William James Gordon-Kamm, Keith S Lowe, Jon Aaron Tucker Reinders, Huaxun Ye
-
Patent number: 11941907Abstract: An acoustic imaging system includes multiple transducers disposed to circumscribe a portion of substrate. An acoustic imaging system also includes a controller and an image resolver. The transducers convert electrical signals into mechanical energy and/or mechanical energy into electrical signals. The controller is adapted to apply an electrical signal to the transducers which, in response, induce a mechanical wave, such as a surface wave, into the circumscribed portion. The controller is also adapted to receive electrical signals from the transducers. The image resolver uses the electrical signals received by the controller in order to construct an image of an object in physical contact with the substrate.Type: GrantFiled: May 20, 2021Date of Patent: March 26, 2024Assignee: Apple Inc.Inventors: Mohammad Yeke Yazdandoost, Giovanni Gozzini, Brian Michael King, Marcus Yip, Marduke Yousefpor, Ehsan Khajeh, Aaron Tucker, Henry H. Yang
-
Publication number: 20240002877Abstract: Parthenogenesis is a natural form of asexual reproduction wherein growth and development of embryos occur without fertilization by sperm. Peptides are used as parthenogenesis factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from female gametes.Type: ApplicationFiled: October 21, 2021Publication date: January 4, 2024Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: SHANE E. ABBITT, JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20230407324Abstract: Methods of creating doubled haploid inducers are provided. These doubled haploid inducers are used in the production of maternal doubled haploids.Type: ApplicationFiled: October 20, 2021Publication date: December 21, 2023Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: JON AARON TUCKER REINDERS, MARK E. WILLIAMS, HUAXUN YE
-
Publication number: 20230343116Abstract: The methods have application to the tissue culture of plant cells, ovules and microspores. Automated imaging, automated cell tracking and predictive modeling are used to develop methods that predict the likelihood that a plant cell will develop into a desired phenotype and/or which cellular reprogramming factors will assist in this development. The methods taught herein can also be used to evaluate the toxicity effects of compounds on plant cells, predict genotypic responses to tissue culture and cellular reprogramming factors, determine cell ploidy status, and predict other types of cell phenotype development.Type: ApplicationFiled: December 17, 2020Publication date: October 26, 2023Applicants: PIONEER HI-BRED INTERNATIONAL, INC., SCREENSYS GMBHInventors: CRISTINA DAL BOSCO, OLEKSANDR DOVZHENKO, JON AARON TUCKER REINDERS, MAJA TEMERINAC-OTT, OLAF TIETZ, SEAN WALSH
-
Publication number: 20230203516Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: ApplicationFiled: August 8, 2022Publication date: June 29, 2023Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: TIM FOX, WILLIAM JAMES GORDON-KAMM, RACHEL CAROL HUEGEL, KEITH S. LOWE, JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20230189734Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing embryogenesis factor genes and/or morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing embryogenesis factor gene products and/or morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Embryogenesis factor proteins and/or developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: ApplicationFiled: October 27, 2022Publication date: June 22, 2023Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: JON AARON TUCKER REINDERS, HUAXUN YE
-
Patent number: 11447786Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: GrantFiled: October 12, 2018Date of Patent: September 20, 2022Inventors: Tim Fox, William James Gordon-Kamm, Rachel Carol Huegel, Keith S Lowe, Jon Aaron Tucker Reinders, Huaxun Ye
-
Publication number: 20220253661Abstract: A method of providing a contactless card having a metal substrate with a first and second, a top and bottom face. A slit can be created in the creating a slit in the metal substrate wherein the slit has ends extending to the edges of the substrate. The method includes filling the slit with a central fill filler material wherein the central fill defines a top void between the central fill and a top plane relative to a top face of the substrate and the central fill defines a bottom void between the central fill and a bottom plane relative to a bottom face of the substrate. The filler material of the central, top, and bottom portions is cured and planned to be flush with the substrate front and back surfaces. The filler material can be a resin and the slit can have generally an āSā configuration or portion thereof.Type: ApplicationFiled: January 3, 2022Publication date: August 11, 2022Applicant: CREDIT CARD SUPPLIES CORPORATIONInventors: Patrick Daley, Edmond Davis, Aaron Tucker
-
Publication number: 20220240467Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing embryogenesis factor genes and/or morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing embryogenesis factor gene products and/or morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Embryogenesis factor proteins and/or developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: ApplicationFiled: April 17, 2020Publication date: August 4, 2022Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20220154203Abstract: The methods disclosed herein provide for clonal plant production using a morphogenic gene to produce non-transgenic and transgenic plants wherein the morphogenic gene does not integrate into the genome of the plant.Type: ApplicationFiled: March 10, 2020Publication date: May 19, 2022Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: WILLIAM JAMES GORDON-KAMM, KEITH S LOWE, JON AARON TUCKER REINDERS, HUAXUN YE
-
Publication number: 20210285006Abstract: Automated, high-throughput and multiplexed methods for clonal plant production from maternal or paternal derived cellular structures including embryos and microspores, using morphogenic factors to produce plants are disclosed. Large scale and rapid clonal propagation methods facilitate increased efficiency in producing doubled haploid plants for breeding and for trait introgression purposes.Type: ApplicationFiled: March 9, 2021Publication date: September 16, 2021Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: WILLIAM JAMES GORDON-KAMM, JON AARON TUCKER REINDERS
-
Publication number: 20210271843Abstract: An acoustic imaging system includes multiple transducers disposed to circumscribe a portion of substrate. An acoustic imaging system also includes a controller and an image resolver. The transducers convert electrical signals into mechanical energy and/or mechanical energy into electrical signals. The controller is adapted to apply an electrical signal to the transducers which, in response, induce a mechanical wave, such as a surface wave, into the circumscribed portion. The controller is also adapted to receive electrical signals from the transducers. The image resolver uses the electrical signals received by the controller in order to construct an image of an object in physical contact with the substrate.Type: ApplicationFiled: May 20, 2021Publication date: September 2, 2021Inventors: Mohammad Yeke Yazdandoost, Giovanni Gozzini, Brian Michael King, Marcus Yip, Marduke Yousefpor, Ehsan Khajeh, Aaron Tucker, Henry H. Yang
-
Patent number: 11048902Abstract: An acoustic imaging system includes multiple transducers disposed to circumscribe a portion of substrate. An acoustic imaging system also includes a controller and an image resolver. The transducers convert electrical signals into mechanical energy and/or mechanical energy into electrical signals. The controller is adapted to apply an electrical signal to the transducers which, in response, induce a mechanical wave, such as a surface wave, into the circumscribed portion. The controller is also adapted to receive electrical signals from the transducers. The image resolver uses the electrical signals received by the controller in order to construct an image of an object in physical contact with the substrate.Type: GrantFiled: August 17, 2016Date of Patent: June 29, 2021Assignee: Appple Inc.Inventors: Mohammad Yeke Yazdandoost, Giovanni Gozzini, Brian Michael King, Marcus Yip, Marduke Yousefpor, Ehsan Khajeh, Aaron Tucker, Henry H. Yang
-
Publication number: 20200263189Abstract: Plant cell fate and development is altered by treating cells with cellular reprogramming factors. Embryogenesis inducing morphogenic developmental genes are used as cellular reprogramming factors, specifically comprising polypeptides or polynucleotides encoding gene products for generating doubled haploids or haploid plants from gametes. Maize microspores treated by contacting the isolated cells with an exogenous purified, recombinant embryogenesis inducing morphogenic developmental gene polypeptide results in embryogenesis. The gametes of a maize plant develop into embryoids when transformed with a genetic construct including regulatory elements and structural genes capable of acting in a cascading fashion to alter cellular fate of plant cells. Developmental morphogenic proteins expressed from a genetic construct are used for ex situ treatment methods and for in planta cellular reprogramming.Type: ApplicationFiled: October 12, 2018Publication date: August 20, 2020Applicant: PIONEER HI-BRED INTERNATIONAL, INC.Inventors: TIM FOX, WILLIAM JAMES GORDON-KAMM, RACHEL CAROL HUEGEL, KEITH S LOWE, JON AARON TUCKER REINDERS, HUAXUN YE